Business News: GE Healthcare to open biotechnology manufacturing center in UK
Facility producing fiber-based chromatography platform for more efficient biopharmaceutical purification operational in 2019
Chalfont St Giles, UK. — November 27 2018 – GE Healthcare today announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage, UK. In the first half of 2019, the center will start producing a fiber-based purification platform, which has the potential to significantly improve efficiency in the purification steps of manufacturing biopharmaceuticals, gene therapies and viral vectors.